Oxygen Therapy: Indications And Device Selection

The administration of supplemental oxygen stands as one of the most fundamental therapeutic interventions in modern healthcare, yet the journey to its systematic clinical use spans several centuries of scientific discovery. Before the isolation and characterization of oxygen as a distinct gas, clinicians had no conceptual framework to explain why patients turned cyanotic, deteriorated in respiratory distress, or died from what we now recognize as hypoxemia—an abnormally low partial pressure of oxygen in arterial blood. The evolution from crude inhalation experiments to precise, evidence-based oxygen delivery systems reflects broader advances in pulmonary physiology, blood gas analysis, and critical care nursing.

This historical progression raises the central clinical question that every nurse must be prepared to answer: given a patient presenting with signs or symptoms of inadequate oxygenation, when is supplemental oxygen indicated, and which delivery device best matches the patient's needs? Answering this question requires integrating knowledge of oxygen physiology, device capabilities, and patient assessment—all of which are tested on the NCLEX-RN under Physiological Integrity.

Before selecting an oxygen delivery device, the nurse must understand the physiological basis for oxygen therapy and the terminology that guides clinical decision-making. Several foundational concepts link the atmospheric oxygen we breathe to the tissue oxygenation that sustains cellular metabolism. A working grasp of these principles ensures that interventions are neither withheld from patients who need them nor applied excessively to patients who may be harmed.

The following diagram illustrates the most commonly used oxygen delivery devices arranged along a continuum of increasing FiO₂ capability. Understanding where each device falls on this spectrum is essential for selecting the appropriate intervention based on clinical presentation and desired oxygen saturation targets. Low-flow devices occupy the left side, providing modest supplementation, while high-flow and reservoir devices dominate the right side, capable of delivering near-100% oxygen concentrations.

When reading the diagram, notice that low-flow devices such as the nasal cannula and simple mask deliver oxygen below the patient's total inspiratory flow—typically 30–60 L/min at rest—which means the patient entrains variable amounts of room air with each breath. This is why the FiO₂ values listed for low-flow devices are approximate ranges rather than fixed numbers. In contrast, the Venturi mask uses a jet-mixing principle with color-coded adaptors to deliver a precise, predictable FiO₂, making it the device of choice for COPD patients who require tightly controlled oxygenation to avoid suppressing their hypoxic ventilatory drive.

Understanding how supplemental oxygen raises the partial pressure of oxygen in alveolar gas—and subsequently in arterial blood—requires revisiting the alveolar gas equation. While nurses do not routinely perform this calculation at the bedside, familiarity with its components clarifies why increasing FiO₂ improves oxygenation and why certain clinical conditions limit the effectiveness of supplemental oxygen alone.

This equation reveals that increasing FiO₂ directly raises PAO₂, which in turn increases the diffusion gradient across the alveolar-capillary membrane, driving more oxygen into arterial blood. However, conditions that impair diffusion (such as pulmonary fibrosis) or create significant intrapulmonary shunting (such as ARDS) may not respond adequately to supplemental oxygen, necessitating mechanical ventilation with positive pressure.

The oxyhemoglobin dissociation curve further contextualizes oxygen therapy decisions. Because the curve has a sigmoidal shape, small decreases in PaO₂ below approximately 60 mmHg produce disproportionately large drops in oxygen saturation. This threshold explains the clinical urgency of treating a PaO₂ below 60 mmHg (corresponding to approximately SpO₂ of 90%)—it places the patient on the steep portion of the curve where even minor additional declines can precipitate tissue hypoxia.

Selecting the appropriate oxygen delivery device requires matching the patient's clinical severity, comfort needs, and desired FiO₂ precision to the characteristics of each device category. The table below provides a comprehensive comparison that serves as a clinical decision-making reference. Nurses must also consider factors such as patient tolerance, risk of aspiration, presence of a tracheostomy, and the need for humidification when making their selection.

The flowchart above illustrates the logical progression of clinical decision-making. The first branch point—determining whether the patient is a chronic CO₂ retainer—is perhaps the most critical because it fundamentally changes the oxygenation target. For COPD patients with chronic hypercapnia, a Venturi mask set to deliver 24–28% is the first-line choice, titrated to an SpO₂ of 88–92%. For all other patients, the nurse assesses hypoxemia severity and escalates from nasal cannula through masks and ultimately to reservoir or high-flow devices as needed. If the patient fails to improve on maximal non-invasive oxygen therapy—typically a non-rebreather at 15 L/min or HFNC at 60 L/min—the nurse should anticipate the need for endotracheal intubation and mechanical ventilation.

Consider the following clinical scenario: Mr. Davis, a 68-year-old male with a history of COPD and chronic bronchitis, presents to the emergency department with increased dyspnea, productive cough, and bilateral wheezing. His baseline SpO₂ on room air is 84%, respiratory rate is 28 breaths/min, and he appears to be using accessory muscles. His most recent ABG on room air shows PaO₂ 52 mmHg, PaCO₂ 58 mmHg, pH 7.32, and HCO₃⁻ 30 mEq/L.

No single oxygen delivery device is universally ideal; each has trade-offs that the nurse must weigh in the context of the individual patient. Comfort, mobility, aspiration risk, the need for precision, and the severity of hypoxemia all influence device selection. The table below consolidates the strengths and limitations of the major device categories to support rapid clinical decision-making.

Oxygen therapy exists on a continuum of respiratory support that extends from simple supplementation through non-invasive ventilation to invasive mechanical ventilation. Understanding where basic oxygen delivery devices end and advanced interventions begin prepares the nurse to anticipate escalation decisions, communicate effectively with the interprofessional team, and recognize the clinical indicators that signal a patient is failing maximal non-invasive support.

The NCLEX-RN frequently tests the nurse's ability to recognize when escalation is needed. Key indicators that a patient requires progression from basic oxygen therapy to NIV or intubation include: persistent SpO₂ below target despite maximal FiO₂, progressive tachypnea with respiratory rates exceeding 30–35 breaths/min, worsening accessory muscle use, paradoxical breathing, altered mental status (confusion, somnolence), and rising PaCO₂ with falling pH on serial ABGs. The nurse must communicate these findings promptly using structured tools such as SBAR and advocate for timely intervention.